In the media

Back to news lobby
Back to news lobby
In the Media 2 mins
June 20, 2022

Replacing microscopes with digitization

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT...
Link to full article

Scopio Labs, a medtech company that develops AI-powered diagnostic platforms for earlier and more accurate detection of cancers, infections, and other diseases, has announced that its ground-breaking X100HT device with Peripheral Blood Smear (PBS) Application has received US FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.

Back to news lobby
Latest press releases and coverage
Press Release
January 14, 2025

Scopio Labs and Siemens Healthineers Extend Alliance to Include Digital Bone Marrow Aspirate Solution

Adding this important digital innovation to the Siemens Healthineers hematology portfolio supports the needs of pathology and hematopathology laboratories and can ultimately lead to better patient outcomes...
Read more
Press Release
September 17, 2024

Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership

We are thrilled to announce the expansion of our long-term partnership with Beckman Coulter Diagnostics to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA)...
Read more
Press Release
July 25, 2024

Scopio Labs Secures $42 Million in Funding Led by Fortissimo Capital

New Funding to Accelerate Scopio Labs' Commercial Growth and Product Innovation in Full-Field Digital Cell Morphology
Read more

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo